EMM Disclosure
February 25 2003 - 6:49AM
UK Regulatory
RNS Number:9379H
Merrill Lynch International
25 February 2003
FORM 38.5 (SUMMARY)
Lodge with Company Announcements Office and the Panel. Use a separate form for each class of
securities in which dealings have been made.
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Name of EMM Merrill Lynch International
Date of disclosure 25 February 2003
Date of dealing 24 February 2003
Telephone number 020 7996 1038
Please see attached disclosure of dealings under Rule 38.5 in the securities of the following companies:
24 February 2003
Celltech Group Plc - Ordinary
Oxford Glycosciences Plc - Common
Cambridge Antibody Tech Group - Common
AMENDMENT
state which element(s) of disclosure was incorrect:
In the case of option business or dealings in derivatives full details should be given on a separate sheet so
that the nature of the dealings can be fully understood. For options this should include the number of
securities under option, the exercise period (or in the case of exercise, the exercise date), the exercise price
and any option money paid or received. For derivatives this should include, at least, the number of reference
securities to which they relate (when relevant), the maturity date (or if applicable the closing out date) and
the reference price.
For full details of disclosure requirements see Rules 8 and 38 of the Code. If in doubt contact the Monitoring
Section of the Panel, Tel. No: 0171 638 0129
FORM 38.5
Lodge with Company Announcements Office and the Panel. Use a separate form for each class of
securities in which dealings have been made.
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in Oxford Glycosciences Plc
Class of security Common
Date of disclosure 25 February 2003
Date of dealing 24 February 2003
Name of EMM Merrill Lynch International
Name of offeree/offeror with whom connected Cambridge Antibody Tech Group
Number of securities purchased 11,619
Highest price paid* GBP 1.92
Lowest price paid* GBP 1.91
Number of securities sold Nil
Highest price paid* n/a
Lowest Price Paid* n/a
*Currency must be stated
FORM 38.5
Lodge with Company Announcements Office and the Panel. Use a separate form for each class of
securities in which dealings have been made.
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in Celltech Group Plc
Class of security Ordinary
Date of disclosure 25 February 2003
Date of dealing 24 February 2003
Name of EMM Merrill Lynch International
Name of offeree/offeror with whom connected Cambridge Antibody Technology Group Plc
Number of securities purchased 32,339
Highest price paid* GBP 3.44
Lowest price paid* GBP 3.40
Number of securities sold 30,425
Highest price paid* GBP 3.48
Lowest price paid* GBP 3.40
*Currency must be stated
FORM 38.5
Lodge with Company Announcements Office and the Panel. Use a separate form for each class of
securities in which dealings have been made.
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in Cambridge Antibody Tech Group
Class of security Common
Date of disclosure 25 February 2003
Date of dealing 24 February 2003
Name of EMM Merrill Lynch International
Name of offeree/offeror with whom connected Cambridge Antibody Tech Group
Number of securities purchased 323
Highest price paid* GBP 4.30
Lowest price paid* GBP 4.27
Number of securities sold Nil
Highest price paid* n/a
Lowest Price Paid* n/a
*Currency must be stated
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMNKPKQBBKDCBB